GVS S.p.A. Achieves Strong Revenue and EBITDA Growth

GVS S.p.A (IT:GVS) has released an update.

GVS S.p.A. reported a solid financial performance for the first nine months of 2024, with consolidated revenues reaching €321.7 million, marking a 3.7% increase at constant exchange rates compared to the previous year. The company’s Healthcare & Lifesciences division, which accounts for the largest portion of its revenue, saw notable growth in its Air & Gas and Laboratory segments. Additionally, normalized EBITDA rose by 13% year-over-year, reflecting improved profit margins.

For further insights into IT:GVS stock, check out TipRanks’ Stock Analysis page.